ATE501759T1 - Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis - Google Patents

Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis

Info

Publication number
ATE501759T1
ATE501759T1 AT07868587T AT07868587T ATE501759T1 AT E501759 T1 ATE501759 T1 AT E501759T1 AT 07868587 T AT07868587 T AT 07868587T AT 07868587 T AT07868587 T AT 07868587T AT E501759 T1 ATE501759 T1 AT E501759T1
Authority
AT
Austria
Prior art keywords
treatment
metal coated
coated nanoparticles
enzymatic dermatitis
dermatitis
Prior art date
Application number
AT07868587T
Other languages
English (en)
Inventor
Salvo Anthony Di
Carolyn J Mordas
Janeta Nikolovski
Benjamin C Wiegand
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE501759T1 publication Critical patent/ATE501759T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07868587T 2006-10-30 2007-10-26 Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis ATE501759T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/554,214 US20080103459A1 (en) 2006-10-30 2006-10-30 Enzyme inhibition using nanoparticles
PCT/US2007/082603 WO2008055049A2 (en) 2006-10-30 2007-10-26 Enzyme inhibition using nanoparticles

Publications (1)

Publication Number Publication Date
ATE501759T1 true ATE501759T1 (de) 2011-04-15

Family

ID=39331215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07868587T ATE501759T1 (de) 2006-10-30 2007-10-26 Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis

Country Status (14)

Country Link
US (1) US20080103459A1 (de)
EP (1) EP2083796B1 (de)
JP (1) JP2010508356A (de)
CN (1) CN101557800B (de)
AT (1) ATE501759T1 (de)
AU (1) AU2007313799A1 (de)
BR (1) BRPI0717880A2 (de)
CA (1) CA2667953A1 (de)
CO (1) CO6210804A2 (de)
DE (1) DE602007013266D1 (de)
ES (1) ES2360638T3 (de)
MX (1) MX2009004787A (de)
RU (1) RU2009120470A (de)
WO (1) WO2008055049A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134052A1 (en) * 2004-12-17 2006-06-22 Cossa Anthony J Compositions comprising polymeric emulsifiers and methods of using same
RU2460532C1 (ru) * 2011-04-28 2012-09-10 Учреждение Российской академии наук Институт энергетических проблем химической физики РАН Препарат, ускоряющий ранозаживление
US20140154468A1 (en) * 2012-12-05 2014-06-05 National Taiwan University Composite of size-controllable metal nanoparticales and the method of making the same
EP2946805A4 (de) * 2013-01-21 2016-10-26 Bukyoung Pharm Co Ltd Mikronadel, form zur herstellung davon und herstellungsverfahren dafür
JP2014234334A (ja) * 2013-06-04 2014-12-15 Dic株式会社 金属ナノ粒子／層状鉱物複合体及びその製造方法
US20180243336A1 (en) * 2015-08-28 2018-08-30 The Regents Of The University Of Michigan Antimicrobial and enzyme inhibitory zinc oxide nanoparticles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556560A (en) * 1983-01-24 1985-12-03 The Procter & Gamble Company Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis
FR2651125B1 (fr) * 1989-08-23 1992-10-02 Roussel Uclaf Compositions pharmaceutiques de type "pates a l'eau".
US6492453B1 (en) 1999-09-24 2002-12-10 Alphagary Corporation Low smoke emission, low corrosivity, low toxicity, low heat release, flame retardant, zero halogen polymeric compositions
US6464994B1 (en) * 2000-01-19 2002-10-15 Mentis Technologies, L.C. Diaper dermatitis preventative medication and a method for making and using same
US20030185901A1 (en) * 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
US6518324B1 (en) 2000-11-28 2003-02-11 Atofina Chemicals, Inc. Polymer foam containing nanoclay
AU2002253882A1 (en) 2001-01-30 2002-08-28 The Procter And Gamble Company Coating compositions for modifying surfaces
JP2004529929A (ja) * 2001-04-23 2004-09-30 ニュクリスト ファーマシューティカルズ コーポレーション アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用
KR100467205B1 (ko) * 2001-07-12 2005-01-24 주식회사 엘지생활건강 항균제를 함유하는 일회용 흡수제품
US20030104019A1 (en) * 2001-11-01 2003-06-05 Mcculloch Laura Composition for reducing enzymatic irritation to skin
US6743463B2 (en) 2002-03-28 2004-06-01 Scimed Life Systems, Inc. Method for spray-coating a medical device having a tubular wall such as a stent
DE602004016022D1 (de) * 2003-10-30 2008-10-02 Mcneil Ppc Inc Zusammengesetzte materialien aus metall beladenen abgeblätterten nanoteilchen
JP2005287985A (ja) * 2004-04-05 2005-10-20 Gha:Kk 炎症／臭い抑制部材及びその製造方法並びにこれを用いた義体及びギブス
BRPI0519604A2 (pt) * 2005-01-05 2009-02-25 Robert Holladay composiÇÕes À base de prata/Água, gÉis de prata e prata; e processos para a produÇço e para a utilizaÇço das mesmas

Also Published As

Publication number Publication date
WO2008055049A3 (en) 2008-10-02
JP2010508356A (ja) 2010-03-18
BRPI0717880A2 (pt) 2015-06-16
ES2360638T3 (es) 2011-06-07
EP2083796A2 (de) 2009-08-05
CN101557800B (zh) 2013-04-24
CO6210804A2 (es) 2010-10-20
RU2009120470A (ru) 2010-12-10
CN101557800A (zh) 2009-10-14
AU2007313799A1 (en) 2008-05-08
MX2009004787A (es) 2009-08-12
CA2667953A1 (en) 2008-05-08
US20080103459A1 (en) 2008-05-01
WO2008055049A2 (en) 2008-05-08
EP2083796B1 (de) 2011-03-16
DE602007013266D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
ATE501759T1 (de) Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis
EP2161316A4 (de) Bewuchshemmungszusammensetzung, verfahren zur herstellung der zusammensetzung, aus der zusammensetzung geformter bewuchshemmungsbeschichtungsfilm, mit dem beschichtungsfilm überzogenes objekt und verfahren zur bewuchshemmungsbehandlung mittels bildung des beschichtungsfilms
WO2007097940A3 (en) Reca inhibitors with antibiotic activity, compositions and methods of use
UA100526C2 (ru) Способ и композиция для обработки семян
MX2007016322A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
EP2313082A4 (de) Kosmetische zusammensetzung gegen alterung der haut mit extrakten aus dem samen von phaseolus radiatus durch fermentation und enzymbehandlung
WO2009114725A3 (en) Mobilization op hematopoietic stem cells using cdc42 inhibitors
MY171866A (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
ATE419859T1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
WO2009158248A3 (en) Method and compositions for improving skin and body appearance
MX2010004886A (es) Metodo para mejorar la apariencia de la piel usando particulas macroscopicas tratadas.
FI20095616A7 (fi) Menetelmä huokoisen tuotteen prosessoimiseksi ja huokoinen tuote
MX2015011544A (es) Metodos y detergentes enzimaticos para la eliminacion de biopelicula.
DE602007008405D1 (de) Ultrahydrophobische oberflächen und herstellungsverfahren dafür
WO2008092099A8 (en) Compositions and methods for treating hematopoietic malignancies
WO2011132874A3 (en) A method for nitriding surface of aluminum or aluminum alloy by cold spray method
WO2012068356A3 (en) Compositions and methods for improving the appearance of facial pores
DE502005001677D1 (de) Verfahren zur Herstellung von Beschichtungen mit strukturierter Oberfläche, verwendet insbesondere für Stifte, und Gegenstand mit strukturierter Oberfläche
GB0817578D0 (en) Method for treating wheel rims and composition for use therein
MX2009004142A (es) Metodo para prevenir o tratar sindrome metabolico.
ATE522210T1 (de) Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung
WO2010065861A3 (en) Inhibitors of bace 1 and methods for treating alzheimer's disease
WO2006104751A3 (en) Methods and compositions for modulating rho-mediated gene transcription
WO2006092650A3 (en) A composition for creating an artificial bone -marrow like environment and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties